In the setting of mucinous carcinoma, SATB2 is a good diagnostic marker since secondary EMPD arising in association with mucinous carcinoma is typically of colorectal origin, and not from non-colorectal sites. The gene discussed is SATB2; the disease is mucinous adenocarcinoma.